Sign In
Buy ALNY
$216.98
-2.22 (-1.01%)
At Close: Aug 10, 2026
Alnylam Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Period Progress
08:00am, Thursday, 30'th Apr 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter ended Ma
Alnylam (ALNY) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
10:15am, Wednesday, 29'th Apr 2026
Beyond analysts' top-and-bottom-line estimates for Alnylam (ALNY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:01am, Monday, 27'th Apr 2026
Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Alnylam (ALNY) is Poised to Beat Earnings Estimates Again
01:11pm, Thursday, 23'rd Apr 2026
Alnylam (ALNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:03am, Thursday, 23'rd Apr 2026
Alnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Brown Advisory Large-Cap Growth Strategy Q1 2026 Portfolio Review
06:45am, Friday, 17'th Apr 2026
Netflix outperformed during the period as investor concerns around a potential acquisition of Warner Bros. Discovery subsided. Microsoft lagged during the quarter despite reporting strong underlying r
Alnylam to Webcast Conference Call Discussing First Quarter 2026 Financial Results
08:00am, Thursday, 16'th Apr 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the first quarter endi
Massachusetts Financial Services Co. MA Boosts Stock Holdings in Alnylam Pharmaceuticals, Inc. $ALNY
05:28am, Monday, 13'th Apr 2026
Massachusetts Financial Services Co. MA lifted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 38.9% during the fourth quarter, according to its most recent disclosure with the
Melissa Mclaughlin Sells 1,624 Shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock
04:03am, Thursday, 09'th Apr 2026
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY - Get Free Report) insider Melissa Mclaughlin sold 1,624 shares of the business's stock in a transaction that occurred on Thursday, April 2nd. The shares we
Melissa Mclaughlin Sells 2,286 Shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock
04:02am, Thursday, 09'th Apr 2026
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY - Get Free Report) insider Melissa Mclaughlin sold 2,286 shares of the company's stock in a transaction that occurred on Monday, April 6th. The stock was so
Is the Options Market Predicting a Spike in Alnylam Pharmaceuticals Stock?
10:11am, Tuesday, 07'th Apr 2026
Investors need to pay close attention to ALNY stock based on the movements in the options market lately.
5 Biotechs That Big Pharma Could Snap Up as Oncology M&A Heats Up
07:05am, Wednesday, 01'st Apr 2026
Oncology M&A activity is accelerating as large pharmaceutical companies race to replenish pipelines facing patent cliffs and seek exposure to next-generation therapeutic platforms.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new clinical and real-world data from its cardiovascular (CV) po
Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Progress and Strategy in Transforming ATTR Amyloidosis Care and Expanding TTR Franchise Transcript
Congress Asset Management Co. Boosts Position in Alnylam Pharmaceuticals, Inc. $ALNY
01:39pm, Tuesday, 24'th Mar 2026
Congress Asset Management Co. boosted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 126.6% in the fourth quarter, according to its most recent 13F filing with the Securities a
